106 related articles for article (PubMed ID: 20473916)
1. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study.
Ben Q; Wang K; Yuan Y; Li Z
Int J Cancer; 2011 Mar; 128(5):1179-86. PubMed ID: 20473916
[TBL] [Abstract][Full Text] [Related]
2. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer.
Wang DS; Chen DL; Ren C; Wang ZQ; Qiu MZ; Luo HY; Zhang DS; Wang FH; Li YH; Xu RH
Int J Cancer; 2012 Jul; 131(2):461-8. PubMed ID: 21858814
[TBL] [Abstract][Full Text] [Related]
3. Association between ABO blood types and sporadic pancreatic neuroendocrine tumors in the Chinese Han population.
Ben Q; Liu J; Wang W; Guo F; Yao W; Zhong J; Yuan Y
Oncotarget; 2017 Aug; 8(33):54799-54808. PubMed ID: 28903383
[TBL] [Abstract][Full Text] [Related]
4. ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer.
Hofmann BT; Stehr A; Dohrmann T; Güngör C; Herich L; Hiller J; Harder S; Ewald F; Gebauer F; Tachezy M; Precht C; Izbicki JR; Bockhorn M; Wagener C; Wolters-Eisfeld G
Clin Cancer Res; 2014 Dec; 20(23):6117-26. PubMed ID: 25320359
[TBL] [Abstract][Full Text] [Related]
5. ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China.
Sheng L; Sun X; Zhang L; Su D
Int J Cancer; 2013 Aug; 133(4):893-7. PubMed ID: 23389798
[TBL] [Abstract][Full Text] [Related]
6. ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer.
Li D; Pise MN; Overman MJ; Liu C; Tang H; Vadhan-Raj S; Abbruzzese JL
Cancer Med; 2015 Nov; 4(11):1651-8. PubMed ID: 26275671
[TBL] [Abstract][Full Text] [Related]
7. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.
El Jellas K; Hoem D; Hagen KG; Kalvenes MB; Aziz S; Steine SJ; Immervoll H; Johansson S; Molven A
Cancer Med; 2017 Jul; 6(7):1531-1540. PubMed ID: 28556564
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China.
Ben Q; Li Z; Liu C; Cai Q; Yuan Y; Wang K; Xiao L; Gao J; Zhang H
Pancreas; 2012 Apr; 41(3):435-40. PubMed ID: 22422136
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism.
Zhou Y; Zhou Q; Lin Q; Chen R; Gong Y; Liu Y; Yu M; Zeng B; Li K; Chen R; Li Z
Int J Cancer; 2013 Oct; 133(8):1867-75. PubMed ID: 23564396
[TBL] [Abstract][Full Text] [Related]
10. ABO blood group and esophageal carcinoma risk: from a case-control study in Chinese population to meta-analysis.
Wang W; Liu L; Wang Z; Lu X; Wei M; Lin T; Zhang Y; Jiang S; Wang Q; Cao Z; Shi M
Cancer Causes Control; 2014 Oct; 25(10):1369-77. PubMed ID: 25064033
[TBL] [Abstract][Full Text] [Related]
11. ABO blood group and the risk of pancreatic cancer.
Wolpin BM; Chan AT; Hartge P; Chanock SJ; Kraft P; Hunter DJ; Giovannucci EL; Fuchs CS
J Natl Cancer Inst; 2009 Mar; 101(6):424-31. PubMed ID: 19276450
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of ABO groups to hypertensive intracerebral hemorrhage].
Chen XH; Deng WM; Zou L; Huang XR; Lu BX; Zhang XL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Nov; 30(11):2521-2. PubMed ID: 21097423
[TBL] [Abstract][Full Text] [Related]
13. ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region.
Engin H; Bilir C; Üstün H; Gökmen A
Asian Pac J Cancer Prev; 2012; 13(1):131-3. PubMed ID: 22502655
[TBL] [Abstract][Full Text] [Related]
14. [Pancreatic cancer and ABO blood types: a study of cases and controls].
Vioque J; Walker AM
Med Clin (Barc); 1991 May; 96(20):761-4. PubMed ID: 1875761
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
Wolpin BM; Kraft P; Gross M; Helzlsouer K; Bueno-de-Mesquita HB; Steplowski E; Stolzenberg-Solomon RZ; Arslan AA; Jacobs EJ; Lacroix A; Petersen G; Zheng W; Albanes D; Allen NE; Amundadottir L; Anderson G; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Clipp S; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs K; Kooperberg C; Lynch SM; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Rajkovic A; Sanchéz MJ; Shu XO; Slimani N; Thomas G; Tobias GS; Trichopoulos D; Vineis P; Virtamo J; Wactawski-Wende J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
Cancer Res; 2010 Feb; 70(3):1015-23. PubMed ID: 20103627
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors, Coronary Severity, Outcome and ABO Blood Group: A Large Chinese Han Cohort Study.
Zhang Y; Li S; Zhu CG; Guo YL; Wu NQ; Xu RX; Dong Q; Liu G; Li JJ
Medicine (Baltimore); 2015 Oct; 94(43):e1708. PubMed ID: 26512559
[TBL] [Abstract][Full Text] [Related]
17. ABO blood groups and risk of deep venous thromboembolism in Chinese Han population from Chaoshan region in South China.
Yu M; Wang C; Chen T; Hu S; Yi K; Tan X
Saudi Med J; 2017 Apr; 38(4):396-399. PubMed ID: 28397946
[TBL] [Abstract][Full Text] [Related]
18. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study.
Ben Q; Cai Q; Li Z; Yuan Y; Ning X; Deng S; Wang K
Eur J Cancer; 2011 Jan; 47(2):248-54. PubMed ID: 20709528
[TBL] [Abstract][Full Text] [Related]
19. ABO Blood Group and Diabetes Mellitus Influence the Risk for Pancreatic Cancer in a Population from China.
Li X; Xu H; Gao P
Med Sci Monit; 2018 Dec; 24():9392-9398. PubMed ID: 30582832
[TBL] [Abstract][Full Text] [Related]
20. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma.
Ben Q; An W; Wang L; Wang W; Yu L; Yuan Y
Pancreas; 2015 Apr; 44(3):471-7. PubMed ID: 25423560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]